Inoue, K., Masumoto, M., Wakakura, M., & al, e. (2011). Ocular hypotensive effect, preservation of visual fields, and safety of adding dorzolamide to prostaglandin therapy for twelve months. Dove Medical Press.
Style de citation Chicago (17e éd.)Inoue, Kenji, Mieko Masumoto, Masato Wakakura, et et al. Ocular Hypotensive Effect, Preservation of Visual Fields, and Safety of Adding Dorzolamide to Prostaglandin Therapy for Twelve Months. Dove Medical Press, 2011.
Style de citation MLA (8e éd.)Inoue, Kenji, et al. Ocular Hypotensive Effect, Preservation of Visual Fields, and Safety of Adding Dorzolamide to Prostaglandin Therapy for Twelve Months. Dove Medical Press, 2011.
Attention : ces citations peuvent ne pas être correctes à 100%.